‘The WOMAN Trial’ is now available as a module for clinicians who care for post-partum patients

20 Sep 2018

A woman bleeds to death after childbirth approximately every ten minutes. Postpartum haemorrhage is the leading cause of maternal death worldwide, with the overwhelming majority of bleeding deaths occurring in low income countries. While the risk of death from postpartum hemorrhage in high income countries is vanishingly low, postpartum haemorrhage is responsible for 100,000 deaths annually. These deaths occur due to a complex network of biological and socioeconomic factors, including changes to haemostasis and fibrinolysis during pregnancy.

‘The WOMAN Trial’ was an ambitious interventional trial collaborated on an epic scale, involving 20,060 women from 193 hospitals in 21 countries and thousands of doctors, midwives and nurses participated.

doctorportal Learning in partnership with Osler have created ‘The WOMAN Trial’ module designed for clinicians who care for post-partum patients, and for whom haemorrhage is a life-threatening event. Accredited for CPD by ACRRM, ACEM, CICM and ANZCA, the module is a well-structured, easy to understand, and step by step guide to understanding the WOMAN trial. The module covers:

  • Study method
  • Results
  • Discussions
  • Knowledge assessment

Sign up for ‘The Woman Trial’ module on doctorportal Learning and understand the methodology, findings and prevention of post-partum haemorrhage deaths.